BDBM50156250 CHEMBL361505::Thiophene-2-sulfonic acid (3-{(R)-1-hydroxy-2-[(R)-2-(7-methoxy-1H-indol-3-yl)-1-methyl-ethylamino]-ethyl}-phenyl)-amide

SMILES COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12

InChI Key InChIKey=GGFAWZQZGYUXOY-IERDGZPVSA-N

Data  3 KI  6 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50156250   

TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataKi:  14nMAssay Description:Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataKi:  25nMAssay Description:Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-2 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataKi:  43nMAssay Description:Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  0.550nMAssay Description:Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  6.60nMAssay Description:Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-2 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  6.60nMAssay Description:Agonist activity at Homo sapiens (human) beta1 adrenoreceptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  29nMAssay Description:Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  0.550nMAssay Description:Agonist activity at Homo sapiens (human) beta3 adrenoreceptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50156250(CHEMBL361505 | Thiophene-2-sulfonic acid (3-{(R)-1...)
Affinity DataEC50:  29nMAssay Description:Agonist activity at Homo sapiens (human) beta2 adrenoreceptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed